The Valley Desk

Clinical trial reportCancer cellPublished

Antigen-specific profiling identifies T-bet+ melanoma-specific CD8+ T cells associated with response to neoadjuvant PD-1 blockade

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer cell
Published
Subject terms
CD8-Positive T-Lymphocytes; Lymphocytes, Tumor-Infiltrating; Humans; Melanoma; Skin Neoplasms; Apyrase; T-Box Domain Proteins; Antigens, Neoplasm; Neoadjuvant Therapy; Prospective Studies; Middle Aged; Female
PubMed ID
41478278
PubMed Central ID
PMC13754276
Added to directory
Source checked

Report a correction or request removal